Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 7/2014

Open Access 01.07.2014 | Original Article

Relationship Between Cytokine Gene Polymorphisms and Risk of Postoperative Pneumonia with Esophageal Cancer

verfasst von: Kazuhiko Sakamoto, Masaaki Oka, Shigehumi Yoshino, Shoichi Hazama, Shigeru Takeda, Kiyoshi Yoshimura, Naoko Okayama, Yuji Hinoda

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 7/2014

Abstract

Background

We retrospectively evaluated the relationship between cytokine gene polymorphisms and development of postoperative pneumonia after esophagectomy.

Methods

In 120 patients who underwent esophagectomy, serum samples were obtained to measure levels of serum interleukin (IL)-6 and IL-10 at four time points (preoperatively, postoperative day (POD)0, POD1, and POD3). DNA extracted from peripheral blood in all patients was analyzed to determine polymorphisms of cytokines such as tumor necrosis factor-α -1031 T/C, IL-1β -511C/T, IL-6 -634C/G, and IL-10 -819 T/C.

Results

Postoperative pneumonia arose in 34 patients (28.3 %). Perioperative serum IL-10 levels were significantly higher for IL-10 -819 C/T + C/C genotypes than for T/T genotypes (POD0 16.7 ± 2.84 vs. 8.54 ± 0.87 pg/ml, p = 0.0002; POD1 14.0 ± 2.64 vs. 8.8 ± 0.87 pg/ml, p = 0.0143; POD3 8.9 ± 2.67 vs. 4.4 ± 0.52 pg/ml, p = 0.0076). The frequency of the IL-10 -819 T/T genotype was significantly higher in patients with postoperative pneumonia than in patients without pneumonia (p = 0.0323). Multivariate analysis of factors such as sex, smoking, length of operation, field of lymph node dissection, and IL-10 polymorphism identified IL-10 polymorphism as independent predictor of postoperative pneumonia.

Conclusions

Patients with IL-10 -819 T/T genotype may be at high risk for postoperative pneumonia after esophagectomy.

Introduction

Surgery for esophageal cancer is one of the most invasive gastrointestinal surgeries,1, 2 and perioperative mortality rates remain in the range of 3–10 %.3 5 In the case of esophageal cancer, marked elevations in cytokine levels are observed perioperatively, inducing a systemic inflammatory response syndrome (SIRS).6, 7 Such hypercytokinemia produces excessive stress and may trigger postoperative complications.8 The lungs is one of the main organs of neutrophil sequestration under conditions of SIRS.9 12 Abe et al. reported that transthoracic esophagectomy causes an increase in interleukin (IL)-6 production from bronchial and alveolar epithelial cells lining the airway, and local response of lung tissue may be one source of increased serum IL-6 after esophagectomy in humans.13 The clinical effects of an immune response are orchestrated by numerous pro-inflammatory, inflammatory, and anti-inflammatory cytokines. Tumor necrosis factor (TNF)-α is a major mediator and amplifier of immune responses to infectious challenges. Azim et al. recently reported that the TNF-α -308 polymorphism contributes to infectious complications after esophagectomy.14 Moreover, associations between infection and genetic polymorphisms have been reported for other cytokines, including IL-1β, IL-6, and IL-10.15 18 These findings suggest that patient genotype may influence susceptibility to postoperative infection.
We have a considerable interest in whether factors such as these polymorphisms might affect the postoperative infection, particularly in terms of the effects on postoperative pneumonia. We selected TNF-α, IL-1β, IL-6, and IL-10 as representative pro-inflammatory, inflammatory, and anti-inflammatory cytokines and investigated the gene promoter polymorphisms of TNF-α -1031 T > C (rs1799964), IL-1β -511 T > C (rs3087258), IL-6 -634G > C (rs1800796), and IL-10 -819 T > C (rs1800871); all of which have been reported to influence cytokine production.18 22 The purpose of this study was to assess whether cytokine promoter gene polymorphisms are associated with the following: (1) perioperative cytokine production and (2) postoperative pneumonia following esophagectomy.

Methods

Patients

This was a retrospective cohort study that included patients treated for esophageal cancer between 1997 and 2011. Participants comprised 120 consecutive Japanese patients (105 men and 15 women) with thoracic esophageal cancer who underwent curative esophagectomy and reconstruction with gastric mobilization via a posterior mediastinal or retrosternal route by right posterolateral thoracotomy and laparotomy consecutively in the Department of Digestive Surgery and Surgical Oncology at Yamaguchi University Graduate School of Medicine. These patients underwent dissection of two (mediastinal and abdominal) or three (bilateral neck, mediastinal, and abdominal) lymph node fields. Patients who received neoadjuvant treatment or underwent reconstruction with small intestine or colon mobilization were excluded. We introduced thoracoscopic procedures in a prone position from 2008 and excluded these procedures from the present study. In all cases, diagnoses of esophageal squamous cell cancer were confirmed preoperatively on the basis of histopathological reports. The clinicopathological definition of thoracic esophageal cancer was based on the International Union against Cancer tumor-node-metastasis (TNM) classification of malignant tumors (6th edition). Written informed consent was obtained from all study patients. The study protocol was approved by the Institutional Review Board for the Use of Human Subjects at Yamaguchi University Graduate School of Medicine.

Perioperative Management

We performed perioperative management as follows. At the first visit to our hospital, all patients were instructed to quit smoking and respiratory rehabilitation was started at the same time. As prophylactic antibiotics, patients received cefazolin 1 g by intravenous infusion for 30 min before the operation. An additional dose was administered if the operation was prolonged beyond 3 h. Patients received the same antibiotics plus further treatment at 12-h intervals, for a total of 5 days. For nutritional support, enteral nutrition was provided via jejunostomy from 6 h postoperatively, and the dose was increased step-by-step to 2,000 kcal/day up to postoperative day (POD) 7. All patients were admitted to the intensive care unit and placed on prophylactic mechanical ventilation. The timing of extubation was decided according to the results of bronchoscopy, blood gas analysis, and chest radiography. The criteria for extubation were as follows: (1) arterial oxygen pressure >100 mmHg with inspired fraction of oxygen (FiO2) 0.4 and (2) absence of atelectasis on bronchoscopic view or radiography.

Postoperative Complications

Postoperative complications were defined as follows. Postoperative pneumonia was diagnosed by the presence of pyrexia >38 °C within 2 weeks postoperatively and either positive sputum cultures or clear clinical or radiological evidence of consolidation. Anastomotic leakage was diagnosed by gastrography and clinical features. Postoperative wound infection was defined as a systemic response to the presence of an infectious agent supported by clinical and laboratory evidence, where laboratory evidence means positive culture results. Cardiac complications including arrhythmia, angina, or heart failure were diagnosed by a cardiologist.

Serum Cytokines

Serum samples were obtained at four time points (preoperatively, end of the operation (POD0), POD1, and POD3) and stored at −80 °C until use. Serum IL-6 and IL-10 levels were measured using commercially available enzyme-linked immunosorbent assay kits (BioSource International, Camarillo, CA). Samples were prepared and tested in duplicate according to the protocol recommended by the manufacturer.

DNA Specimens and Genotyping

For DNA analysis, 7 ml of peripheral blood was obtained from all patients. DNA was isolated by a conventional NaI method and stored at 4 °C.23 All polymorphisms were identified with the tetra-primer amplification refractory mutation system-polymerase chain reaction (ARMS-PCR), and details of primers and PCR conditions have been described in the literature.24 26

Statistical Analysis

Data are expressed as mean values±standard error and were analyzed using the Mann-Whitney U test. Categorical data were analyzed using the χ2 test or Fisher’s exact test. Differences in genotype frequency were analyzed using the χ2 test or Fisher’s exact test of independence, with which, each of the genotype frequencies was evaluated to determine whether it was consistent with expected Hardy-Weinberg proportions. Because homozygotes for the rare allele were too few to perform a 2 × 3 χ2 test or Fisher’s exact test, homozygotes of the dominant alleles and variant carriers were compared by 2 × 2 test. Variables with a p < 0.2 in the univariate analysis that were potentially predictive of postoperative pneumonia were then entered into the multivariate logistic regression model. Odds ratio (OR) and 95 % confidence interval (CI) were also calculated. A value of p < 0.05 was considered statistically significant. All analyses were performed using StatView version 5.0 statistical software (SAS Institute, Cary, NC).

Results

In all 120 patients studied, the frequency of postoperative pneumonia was 28.3 % (34 of 120 patients). In terms of other complications, 14 patients (11.7 %) developed wound infection, 8 patients (6.7 %) developed anastomotic leakage, and 25 patients (20.8 %) developed cardiac complications. Perioperative patient- and tumor-related factors and other complications were compared between groups with and without postoperative pneumonia (Table 1). The proportion of males was significantly higher among patients with pneumonia (97.1 %) than among patients without pneumonia (82.6 %; p = 0.0384). The proportions of smoking, 3-field lymph node dissection, and the length of operation tended to be higher among patients with pneumonia than among patients without pneumonia (p = 0.147, p = 0.102, and p = 0.0679, respectively).
Table 1
Patient characteristics in the two groups
 
Pneumonia + (n = 34)
Pneumonia − (n = 86)
p value
Age
63.7 ± 8.9
63.0 ± 9.2
0.337
Gender
 Male
33
71
 
 Female
01
15
0.0384
Body mass index (kg/m2)
21.0 ± 3.0
21.1 ± 3.0
0.954
Smoking
 Yes
32
71
 
 No
02
15
0.147
FEV1.0 %
73.2 ± 12.2
73.1 ± 8.8
0.592
Preoperative CRP (mg/dl)
0.82 ± 2.4
0.32 ± 0.47
0.765
Tumor locations
 Upper
04
09
 
 Middle
21
44
 
 Lower
09
33
0.465
UICC stage (pathological)
 I and II
21
50
 
 III and IV
13
36
0.716
Length of operation (min)
463 ± 100
433 ± 99
0.0679
Blood loss (g)
820 ± 913
548 ± 267
0.283
Field of lymph node dissection
 2 (mediastinum and abdomen)
22
68
 
 3 (bilateral neck, mediastinum, and abdomen)
12
18
0.102
Wound infection
 Yes
5
09
 
 No
29
77
0.536
Anastomotic leakage
 Yes
03
05
 
 No
31
81
0.686
Cardiac complications
 Yes
09
16
 
 No
25
70
0.339
Data are presented as mean+standard error or absolute numbers
FEV forced expiratory volume, CRP C-reactive protein, UICC International Union Against Cancer
No relationship was seen between perioperative serum IL-6 levels and polymorphisms (Fig. 1). Perioperative serum IL-10 levels were significantly higher for IL-10 -819 C/T+C/C genotypes than for T/T genotypes (POD0 16.7 ± 2.84 vs. 8.54 ± 0.87 pg/ml, p = 0.0002; POD1 14.0 ± 2.64 vs. 8.8 ± 0.87 pg/ml, p = 0.0143; POD3 8.9 ± 2.69 vs. 4.4 ± 0.52 pg/ml, p = 0.0076) (Fig. 2).
Among the cytokine promoter gene polymorphisms analyzed, a significant association with pneumonia was found for IL-10 -819 T/C. The frequency of the IL-10 -819 T/T genotype was significantly higher in patients with pneumonia than in those without pneumonia (p = 0.0323) (Table 2).
Table 2
Genotype distribution in the postoperative pneumonia
Cytokine polymorphism
Pneumonia + (n = 34)
Pneumonia − (n = 86)
p value
TNF-α -1031
T/T
21
62
0.27
T/C + C/C
13
24
IL-1β -511
C/C
08
26
0.463
C/T+T/T
26
60
IL-6 -634
G/G
20
47
0.678
G/C+C/C
14
39
IL-10 -819
T/T
22
37
0.0323
T/C+C/C
12
49
TNF tumor necrosis factor, IL interleukin
Although no relationship was seen between postoperative serum IL-10 levels and Il-10 polymorphisms in patients with pneumonia, these levels were significantly higher for IL-10 -819 T/C + C/C genotypes than for T/T genotypes in patients without pneumonia (Table 3).
Table 3
Trend in serum IL-10 levels according to IL-10 -819 polymorphism with and without pneumonia
 
Pneumonia ± (n = 34)
p value
Pneumonia − (n = 86)
p value
T/T (n = 22)
T/C±C/C (n = 12)
T/T (n = 37)
T/C±C/C (n = 49)
Serum IL-10 level (pg/ml)
 POD0
9.5 ± 1.6
17.4 ± 5.3
0.65
8.0 ± 1.0
16.5 ± 3.3
<0.01
 POD1
10.1 ± 1.8
10.9 ± 4.0
0.62
8.0 ± 0.9
14.8 ± 3.2
<0.01
 POD3
5.3 ± 0.9
6.2 ± 3.0
0.77
3.8 ± 0.6
9.6 ± 3.3
<0.01
Data are presented as mean±standard error
IL interleukin, POD postoperative day
Clinicopathological variables, including sex (male vs. female), smoking (yes vs. no), length of operation, field of lymph node dissection (three vs. two), and IL-10 -819 polymorphism (T/T vs. C/T + C/C) were entered into a multivariate logistic regression model to identify factors influencing pneumonia (Table 4). Only IL-10 -819 polymorphism was significantly associated with pneumonia (p = 0.0334, OR = 2.68, 95 % CI = 1.08–6.67).
Table 4
Logistic regression predicting development of postoperative pneumonia
 
OR
95 % CI
p value
Gender (male vs. female)
4.64
0.491–43.9
0.18
Smoking (yes vs. no)
1.35
0.235–7.72
0.738
Length of operation (min)
1.002
0.998–1.007
0.276
Field of lymph node dissection (3 vs. 2)
1.43
0.516–3.97
0.491
IL-10 Genotype (T/T vs. C/T+C/C)
2.68
1.08–6.67
0.0334
OR odds ratios, CI confidence interval, IL interleukin

Discussion

This study revealed that IL-10 -819 polymorphism is associated with postoperative pneumonia in Japanese patients with esophageal cancer. The IL-10 -819 TT genotype is related to lower perioperative production of serum IL-10 level. No associations with any other cytokine polymorphism for TNF-α, IL-1β, or IL-6 were evident. Presence of the IL-10 -819 TT genotype seems to confer lower IL-10 release in response to surgical stress and an increased risk of postoperative pneumonia.
Under highly inflammatory conditions such as following esophagectomy, a genotype associated with high anti-inflammatory response may be protective against the development of postoperative respiratory inflammation. IL-10 is a potent endogenous anti-inflammatory cytokine that decreases lung inflammation, partly on the basis of TNF-α and IL-1β.27 Alveolar macrophages produce significant amounts of IL-10.28, 29 Morita reported that IL-10 production after rat thoracotomy was higher from the collapsed lung than from the uncollapsed lung, possibly reflecting suppression of IL-6 production from the collapsed lung.30 These findings are supported by the clinical observation that decreased IL-10 concentration in bronchoalveolar lavage fluid is associated with worse outcomes in patients with the acute respiratory distress syndrome.31 IL-10 therapy increased survival both in a rabbit Pseudomonas aeruginosa pneumonia model and in a murine pneumococcal pneumonia model.32 Those results indicate that IL-10 is a key regulator of the degree of inflammation in the setting of acute lung infection or inflammation.
The current finding that the high IL-10-producing -819C allele is protective against postoperative respiratory inflammation following esophagectomy is consistent with the role of intense inflammation. Lowe et al. reported that the IL-10 -592 CC polymorphism was associated with higher IL-10 release under lipopolysaccharide stimulation and lower mortality in critically ill patients.20 Similar frequencies were obtained for -819 T/C and -592 A/C in all types of participants, indicating complete linkage.33 Those findings are consistent with our own results. However, in critically ill patients with sepsis, the mortality rate was significantly higher in patients with the -592 CC genotype than in those with the -592 AA genotype.33 The overall balance between pro- and anti-inflammatory responses is important in response to injury or surgery. In patients with sepsis, a genotype associated with high IL-10 production may lead to greater immunosuppression, resulting in more severe disease burden and outcomes. In contrast, the present findings were obtained following esophagectomy. In such cases, a genotype associated with high IL-10 may have beneficial modulating effects. The notion that a high IL-10-producing -819 C allele may not be universally detrimental appears reasonable.
Azim et al. reported that not IL-10 -819 T/C but TNF-α-308G/A polymorphism contributes to infectious complications after esophagectomy.14 That result differs from the findings of the present study. However, the frequency of the -308 A allele for TNF-α is much lower in Japanese populations (1.1–1.3 %) than in Caucasians (10–18 %).33 36 Furthermore, the frequency of the -819 C allele of IL-10 in Japanese (30.5–33.6 %) was lower than in Caucasians (79–82 %).20, 33, 37 These results suggest that considering the influence of ethnic differences in gene polymorphism may be important. Further studies on gene polymorphisms in different ethnicities are needed to allow tailoring of specific therapies. Identifying IL-10 polymorphisms in patients prior to esophagectomy may influence management decisions where controversy currently exists, such as the use of other therapeutic strategies. For example, whether steroids should be used to treat patients perioperatively remains unresolved.38 Some patients may benefit, while others may not, depending on individual genotypes. Genotyping this IL-10 polymorphism in patients following esophagectomy may allow better risk stratification and tailoring of specific therapies to different risk groups.

Conflict of Interest

There are no conflicts of interest.
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Haga Y, Beppu T, Doi K, et al. Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Critical care medicine 1997; 25(12): 1994-2000.PubMedCrossRef Haga Y, Beppu T, Doi K, et al. Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Critical care medicine 1997; 25(12): 1994-2000.PubMedCrossRef
2.
Zurück zum Zitat Ono S, Aosasa S, Mochizuki H. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy. Am J Surg 1999; 177(1): 78-82.PubMedCrossRef Ono S, Aosasa S, Mochizuki H. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy. Am J Surg 1999; 177(1): 78-82.PubMedCrossRef
3.
Zurück zum Zitat Poon RT, Law SY, Chu KM, Branicki FJ, Wong J. Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management. Annals of surgery 1998; 227(3): 357-64.PubMedCentralPubMedCrossRef Poon RT, Law SY, Chu KM, Branicki FJ, Wong J. Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management. Annals of surgery 1998; 227(3): 357-64.PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003; 75(1): 217-22; discussion 22.PubMedCrossRef Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003; 75(1): 217-22; discussion 22.PubMedCrossRef
5.
Zurück zum Zitat Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg 2004; 78(4): 1170-6; discussion 70-6.PubMedCrossRef Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg 2004; 78(4): 1170-6; discussion 70-6.PubMedCrossRef
6.
Zurück zum Zitat Maeba T, Maeta H, Usuki H, et al. Increase in portal blood interleukin-6 soon after the commencement of digestive surgery. Surg Today 1996; 26(11): 890-4.PubMedCrossRef Maeba T, Maeta H, Usuki H, et al. Increase in portal blood interleukin-6 soon after the commencement of digestive surgery. Surg Today 1996; 26(11): 890-4.PubMedCrossRef
7.
Zurück zum Zitat Hisano S, Sakamoto K, Ishiko T, Kamohara H, Ogawa M. IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field. Cytokine 1997; 9(6): 447-52.PubMedCrossRef Hisano S, Sakamoto K, Ishiko T, Kamohara H, Ogawa M. IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field. Cytokine 1997; 9(6): 447-52.PubMedCrossRef
8.
Zurück zum Zitat Roumen RM, Hendriks T, van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Annals of surgery 1993; 218(6): 769-76.PubMedCentralPubMedCrossRef Roumen RM, Hendriks T, van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Annals of surgery 1993; 218(6): 769-76.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Kitagawa Y, Van Eeden SF, Redenbach DM, et al. Effect of mechanical deformation on structure and function of polymorphonuclear leukocytes. J Appl Physiol 1997; 82(5): 1397-405.PubMed Kitagawa Y, Van Eeden SF, Redenbach DM, et al. Effect of mechanical deformation on structure and function of polymorphonuclear leukocytes. J Appl Physiol 1997; 82(5): 1397-405.PubMed
10.
Zurück zum Zitat Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001; 7(1): 1-7.PubMedCrossRef Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001; 7(1): 1-7.PubMedCrossRef
11.
Zurück zum Zitat Razavi HM, Wang le F, Weicker S, et al. Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. American journal of respiratory and critical care medicine 2004; 170(3): 227-33. Razavi HM, Wang le F, Weicker S, et al. Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. American journal of respiratory and critical care medicine 2004; 170(3): 227-33.
12.
Zurück zum Zitat Lin X, Yang H, Sakuragi T, et al. Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis. Am J Physiol Lung Cell Mol Physiol 2005; 289(4): L583-90.PubMedCrossRef Lin X, Yang H, Sakuragi T, et al. Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis. Am J Physiol Lung Cell Mol Physiol 2005; 289(4): L583-90.PubMedCrossRef
13.
Zurück zum Zitat Abe T, Oka M, Tangoku A, et al. Interleukin-6 production in lung tissue after transthoracic esophagectomy. J Am Coll Surg 2001; 192(3): 322-9.PubMedCrossRef Abe T, Oka M, Tangoku A, et al. Interleukin-6 production in lung tissue after transthoracic esophagectomy. J Am Coll Surg 2001; 192(3): 322-9.PubMedCrossRef
14.
Zurück zum Zitat Azim K, McManus R, Brophy K, et al. Genetic polymorphisms and the risk of infection following esophagectomy. positive association with TNF-alpha gene -308 genotype. Annals of surgery 2007; 246(1): 122-8.PubMedCentralPubMedCrossRef Azim K, McManus R, Brophy K, et al. Genetic polymorphisms and the risk of infection following esophagectomy. positive association with TNF-alpha gene -308 genotype. Annals of surgery 2007; 246(1): 122-8.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Chang YH, Lee DS, Jo HS, et al. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population. Cytokine 2006; 36(1-2): 45-50. Chang YH, Lee DS, Jo HS, et al. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population. Cytokine 2006; 36(1-2): 45-50.
16.
Zurück zum Zitat Allen ML, Hoschtitzky JA, Peters MJ, et al. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Critical care medicine 2006; 34(10): 2658-65.PubMedCrossRef Allen ML, Hoschtitzky JA, Peters MJ, et al. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Critical care medicine 2006; 34(10): 2658-65.PubMedCrossRef
17.
Zurück zum Zitat Sainz J, Perez E, Gomez-Lopera S, et al. Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients. Cytokine 2008; 41(3): 268-78.PubMedCrossRef Sainz J, Perez E, Gomez-Lopera S, et al. Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in haematological patients. Cytokine 2008; 41(3): 268-78.PubMedCrossRef
18.
Zurück zum Zitat Watanabe E, Hirasawa H, Oda S, et al. Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications. J Trauma 2005; 59(5): 1181-9; discussion 89-90.PubMedCrossRef Watanabe E, Hirasawa H, Oda S, et al. Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications. J Trauma 2005; 59(5): 1181-9; discussion 89-90.PubMedCrossRef
19.
Zurück zum Zitat Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003; 88(1): 255-9.PubMedCrossRef Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003; 88(1): 255-9.PubMedCrossRef
20.
Zurück zum Zitat Lowe PR, Galley HF, Abdel-Fattah A, Webster NR. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Critical care medicine 2003; 31(1): 34-8.PubMedCrossRef Lowe PR, Galley HF, Abdel-Fattah A, Webster NR. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Critical care medicine 2003; 31(1): 34-8.PubMedCrossRef
21.
Zurück zum Zitat Silkov AN, Sennikova NS, Goreva EP, Lopatnikova YA, Sennikov SV. Production of TNF-alpha and IL-1beta by peripheral blood mononuclear cells in carriers of different allele variants of the gene. Bull Exp Biol Med 2012; 153(1): 68-71.PubMedCrossRef Silkov AN, Sennikova NS, Goreva EP, Lopatnikova YA, Sennikov SV. Production of TNF-alpha and IL-1beta by peripheral blood mononuclear cells in carriers of different allele variants of the gene. Bull Exp Biol Med 2012; 153(1): 68-71.PubMedCrossRef
22.
Zurück zum Zitat Soga Y, Nishimura F, Ohyama H, et al. Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863, -857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J Clin Periodontol 2003; 30(6): 524-31.PubMedCrossRef Soga Y, Nishimura F, Ohyama H, et al. Tumor necrosis factor-alpha gene (TNF-alpha) -1031/-863, -857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J Clin Periodontol 2003; 30(6): 524-31.PubMedCrossRef
23.
Zurück zum Zitat Wang L, Hirayasu K, Ishizawa M, Kobayashi Y. Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated Nal and SDS. Nucleic Acids Res 1994; 22(9): 1774-5.PubMedCentralPubMedCrossRef Wang L, Hirayasu K, Ishizawa M, Kobayashi Y. Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated Nal and SDS. Nucleic Acids Res 1994; 22(9): 1774-5.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Hamajima N, Saito T, Matsuo K, et al. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 2000; 91(9): 865-8.PubMedCrossRef Hamajima N, Saito T, Matsuo K, et al. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 2000; 91(9): 865-8.PubMedCrossRef
25.
Zurück zum Zitat Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29(17): E88-8.PubMedCentralPubMedCrossRef Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29(17): E88-8.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Okayama N, Fujimura K, Nakamura J, et al. Evaluation of a new efficient procedure for single-nucleotide polymorphism genotyping: tetra-primer amplification refractory mutation system-polymerase chain reaction. Clin Chem Lab Med 2004; 42(1): 13-6.PubMedCrossRef Okayama N, Fujimura K, Nakamura J, et al. Evaluation of a new efficient procedure for single-nucleotide polymorphism genotyping: tetra-primer amplification refractory mutation system-polymerase chain reaction. Clin Chem Lab Med 2004; 42(1): 13-6.PubMedCrossRef
27.
Zurück zum Zitat Thomassen MJ, Divis LT, Fisher CJ. Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. Clin Immunol Immunopathol 1996; 80(3 Pt 1): 321-4.PubMedCrossRef Thomassen MJ, Divis LT, Fisher CJ. Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. Clin Immunol Immunopathol 1996; 80(3 Pt 1): 321-4.PubMedCrossRef
28.
Zurück zum Zitat Wilkes DS, Neimeier M, Mathur PN, et al. Effect of human lung allograft alveolar macrophages on IgG production: immunoregulatory role of interleukin-10, transforming growth factor-beta, and interleukin-6. Am J Respir Cell Mol Biol 1995; 13(5): 621-8.PubMedCrossRef Wilkes DS, Neimeier M, Mathur PN, et al. Effect of human lung allograft alveolar macrophages on IgG production: immunoregulatory role of interleukin-10, transforming growth factor-beta, and interleukin-6. Am J Respir Cell Mol Biol 1995; 13(5): 621-8.PubMedCrossRef
29.
Zurück zum Zitat Toossi Z, Hirsch CS, Hamilton BD, et al. Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes. J Immunol 1996; 156(9): 3461-8.PubMed Toossi Z, Hirsch CS, Hamilton BD, et al. Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes. J Immunol 1996; 156(9): 3461-8.PubMed
30.
Zurück zum Zitat Morita K. The Effects of One-Lung Ventilation on Cytokine Production from Lung Tissue of Rat Is One-Lung Ventilation Reasonable for Thoracic Surgery? Bull Yamaguchi Med Sch 2003; 50: 65-75. Morita K. The Effects of One-Lung Ventilation on Cytokine Production from Lung Tissue of Rat Is One-Lung Ventilation Reasonable for Thoracic Surgery? Bull Yamaguchi Med Sch 2003; 50: 65-75.
31.
Zurück zum Zitat Donnelly SC, Strieter RM, Reid PT, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996; 125(3): 191-6.PubMedCrossRef Donnelly SC, Strieter RM, Reid PT, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996; 125(3): 191-6.PubMedCrossRef
32.
Zurück zum Zitat Wang E, Simard M, Ouellet N, et al. Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia. J Infect Dis 2000; 182(4): 1255-9.PubMedCrossRef Wang E, Simard M, Ouellet N, et al. Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia. J Infect Dis 2000; 182(4): 1255-9.PubMedCrossRef
33.
Zurück zum Zitat Nakada TA, Hirasawa H, Oda S, et al. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. J Surg Res 2005; 129(2): 322-8.PubMedCrossRef Nakada TA, Hirasawa H, Oda S, et al. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. J Surg Res 2005; 129(2): 322-8.PubMedCrossRef
34.
Zurück zum Zitat Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. Jama 1999; 282(6): 561-8.PubMedCrossRef Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. Jama 1999; 282(6): 561-8.PubMedCrossRef
35.
Zurück zum Zitat Waterer GW, Quasney MW, Cantor RM, Wunderink RG. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. American journal of respiratory and critical care medicine 2001; 163(7): 1599-604.PubMedCrossRef Waterer GW, Quasney MW, Cantor RM, Wunderink RG. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. American journal of respiratory and critical care medicine 2001; 163(7): 1599-604.PubMedCrossRef
36.
Zurück zum Zitat Furuta M, Yano Y, Ito K, et al. Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. Diabetes research and clinical practice 2002; 56(2): 141-5.PubMedCrossRef Furuta M, Yano Y, Ito K, et al. Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. Diabetes research and clinical practice 2002; 56(2): 141-5.PubMedCrossRef
37.
Zurück zum Zitat Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24(1): 1-8.PubMedCrossRef Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24(1): 1-8.PubMedCrossRef
38.
Zurück zum Zitat Shimada H, Ochiai T, Okazumi S, et al. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery 2000; 128(5): 791-8.PubMedCrossRef Shimada H, Ochiai T, Okazumi S, et al. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery 2000; 128(5): 791-8.PubMedCrossRef
Metadaten
Titel
Relationship Between Cytokine Gene Polymorphisms and Risk of Postoperative Pneumonia with Esophageal Cancer
verfasst von
Kazuhiko Sakamoto
Masaaki Oka
Shigehumi Yoshino
Shoichi Hazama
Shigeru Takeda
Kiyoshi Yoshimura
Naoko Okayama
Yuji Hinoda
Publikationsdatum
01.07.2014
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 7/2014
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-014-2531-3

Weitere Artikel der Ausgabe 7/2014

Journal of Gastrointestinal Surgery 7/2014 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.